Skip to main content
Clinical Trials/ISRCTN48327946
ISRCTN48327946CompletedNot Applicable

Gait analysis of changes in clinical and biomechanical parameters in osteoarthritis knee patients after intra-articular infiltration with high molecular weight hyaluronic acid (Hyalubrix®): a randomised intra-patient comparison clinical study

Fidia Farmaceutici S.p.A. (Italy)0 sites30 target enrollmentStarted: July 21, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Aged at least 40 years old, either sex
  • 2. Presence of grade 2 or 3 (according to the Kellegren and Lawrence scale) osteoarthritis (OA) of one knee
  • 3. Knee with pain greater than 4 on the Numerical Rating Scale (NRS)

Exclusion Criteria

  • 1. Concurrent presence of pathologies such as rheumatoid arthritis, gout, hip arthritis
  • 2. Presence of skin infections near the knee
  • 3. Use of corticosteroid in the last 3 months
  • 4. Simultaneous anticoagulant therapy
  • 5. Use of joint protective drugs
  • 6. Clotting anomalies
  • 7. Knee valgus
  • 8. Known adverse reactions to hyaluronic acid
  • 9. Presence of knee replacement or impending knee replacement surgery

Investigators

Sponsor
Fidia Farmaceutici S.p.A. (Italy)

Similar Trials

Gait analysis of changes in clinical and... | Clinical Trial